Skip to main content
. 2020 Jan 9;16:119–129. doi: 10.2147/NDT.S231352

Table 3.

Genotype and Allele Frequency of KCNJ10 Between Drug Resistant and Responsive Patients

SNP Locus Genotype and Allele AED Resistant N=222 AED Responsive N=288 OR (95% CI) p
rs12122979 GG 105 (47.9%) 148 (52.5%) Reference
GA 90 (41.4%) 95 (33.7%) 1.334 (0.910–1.957) 0.140
AA 24 (11.0%) 39 (13.8%) 0.832 (0.470–1.473) 0.528
G 300 (68.5%) 391 (69.3%) 1.039 (0.794–1.361) 0.777
A 138 (31.5%) 173 (30.7%)
rs1186685 TT 126 (57.5%) 176 61.5%) Reference
TC 77 (35.2%) 88 (30.8%) 1.125 (0.828–1.782) 0.320
CC 16 (7.3%) 22 (7.7%) 0.975 (0.480–1.908) 0.900
T 329 (75.1%) 440 (76.9%) 1.104 (0.825–1.478) 0.504
C 109 (24.9%) 132 (23.1%)
rs6690889 TT 110 (50.2%) 162 (57.7%) Reference
TC 90 (41.1%) 92 (32.7%) 1.428 (0.977–2.087) 0.066
CC 19 (8.7%) 27 (9.6%) 0.981 (0.515–1.868) 0.954
T 310 (70.8%) 416 (74.0%) 1.176 (0.899–1.555) 0.254
C 128 (29.2%) 146 (26.0%)
rs2486253 GG 213 96.8%) 272 (95.8%) Reference
GT 7 (3.2%) 12 (4.2%) 0.823 (0567–1.195) 0.305
GG 0 (0.0%) 0 (0.0%)
G 433 (98.4%) 556 (97.9%) 1.335 (0.521–3.420) 0.545
T 7 (1.6%) 12 (2.1%)
rs1186675 CC 197 (89.1%) 258 (90.5%) Reference
CT 23 (10.4%) 24 (9.1%) 1.150 (0635–2.083) 0.645
TT 1 (0.5%) 1 (0.4%) 1.280 (0.079–20.676) 0.862
C 417 (94.3%) 542 (95.1) 0.861 (0.495–1.500) 0.276
T 25 (5.7%) 28 (4.9%)
rs12402969 TT 194 (88.2%) 242 (85.5%) Reference
TC 24 (10.9%) 38 (13.4%) 0.796 (0.460–1.475) 0.413
CC 2 (0.9%) 3 (1.1%) 0.835 (0.137–5.077) 0.844
T 412 (93.6%) 522 (92.2%) 0.806 (0.493–1.318) 0.389
C 28 (6.4%) 44 (7.8%)
rs12729701 AA 127 (58.0%) 163 (57.6) Reference
AG 80 (36.5%) 106(37.5%) 0.949(0.653–1.378) 0.782
GG 12 (5.5%) 14 (4.9%) 1.151 (0.513–2.584) 0.734
A 334 (76.3%) 432 (76.3%) 0.996 (0.743–1.336) 0.980
G 104 (23.7%) 134 (23.7%)
rs1890532 CC 137 (62.3%) 182 (64.5%) Reference
CG 65 (29.3%) 86 (30.5%) 1.007 (0.860–1.419) 0.972
GG 18 (8.2%) 14 (5.0%) 1.706 (0.819–3.555) 0.154
C 339 (77.0%) 450 (79.8%) 0.850 (0.628–1.150) 0.293
G 101 (23.0%) 114 (20.2%)
rs3795339 GG 217 (98.6%) 274 (96.5%) Reference
GA 3 (1.4%) 10 (3.5%) 0.388 (0.105–1.433) 0.155
AA 0 (0.0%) 0 (0.0%)
G 437 (99.3%) 558 (98.2%) 2.611 (0.714–9.543) 0.132
A 3 (0.7%) 10 (1.8%)

Notes: After multiple testing correction by using Bonferroni’s method, p<0.006 is accepted to be significant.